ContraFect Corporation Stock Statistics
Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).
| Dates | Signal | Change |
|---|---|---|
| 2023-01-25 - 2023-01-27 | SELL | -31.57 |
| 2023-01-24 - 2023-01-25 | HOLD | -15.81 |
| 2023-01-12 - 2023-01-24 | SELL | 20.10 |
| 2023-01-10 - 2023-01-12 | HOLD | -5.71 |
| 2022-12-01 - 2023-01-10 | SELL | -33.38 |
Stock Score Effectiveness
Bollinger Stock Signal Effectiveness
Macd Signal Effectiveness
Mv7 Signal Effectiveness
Score signal
Bollinger Signal Statistics
MV signal statistics
MACD Signal Statistics
About ContraFect Corporation
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia. The company also develops CF-296, an engineered lysin, used for treatment of the in... CFRX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
